- Abstract Number: 0718
Obesity Impairs Achievement of Clinical Inactive Disease (CID) in Patients with Juvenile Idiopathic Arthritis (JIA) Treated with TNF Inhibitors
- Abstract Number: 0196
Objectively-Measured Obstructive Sleep Apnea Is Frequent Among Individuals with Rheumatoid Arthritis
- Abstract Number: 1642
Observed Efficacy with Subcutaneous Tanezumab Is Early and Maintained in Patients with Osteoarthritis: Results from a 56-Week Randomized NSAID-Controlled Study
- Abstract Number: 1765
Obstetric Outcomes in Younger Women Less Than 21 Years of Age Compared to Women Between Age 21 and 25 Years with Rheumatic Disease
- Abstract Number: 1501
Obstetrical Outcome and Thromboses in a Multicentric Cohort of Antiphospholipid Syndrome (APS) Patients with Severe Preeclampsia: An Analysis of APS Classification Criteria
- Abstract Number: 0944
Obstructive Sleep Apnea in Fibromyalgia Patients: A Meta-analysis
- Abstract Number: 1036
Ocular Involvement and Treatment in Sarcodosis. Study of 41 Patients of a Series of 383 Patients from a Single University Hospital
- Abstract Number: 1044
Ocular Manifestations in Inflammatory Bowel Disease. Study of 1442 Patients from a Single Referral Center
- Abstract Number: 1043
Ocular Scleral Pathology and Immune-Mediated Inflammatory Diseases. Study of 170 Patients from a Single Universitary Center
- Abstract Number: 2011
Olokizumab Improves Patient Reported Outcomes in Patients with Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate: Results from the Double-Blind, Randomized Controlled Phase III Study
- Abstract Number: 1921
Ongoing Vascular 18F-FDG Uptake Despite Clinical Remission in Patients Receiving Tocilizumab for Large Vessel Vasculitis-Giant Cell Arteritis: Single Universitary Center Experience of 30 Patients
- Abstract Number: PP06
Only in My Dreams Can I Do the Things I Used to Do: Where There Is Research, There Is Hope
- Abstract Number: 1566
Onset and Disease Course of Inflammatory Arthritis in Patients Receiving Immune Checkpoint Inhibitor Therapy at a Single Institution
- Abstract Number: 1281
Opioid-Related Encounters as a Predictor of 30-Day Readmissions in Lupus
- Abstract Number: 0402
Optical Coherence Tomography of the Skin Detects Scleroderma Changes in Clinically Unaffected Skin: An Opportunity for Early Detection of Systemic Sclerosis
- Abstract Number: 1553
Optical Tomography Can Accurately Diagnose Lupus Arthritis
- Abstract Number: 0833
Optimized Treatment of Biological Disease Modifying Drugs in Routine Clinical Practice: Survival Study and Analysis of Patient Characteristics
- Abstract Number: 1021
Organ Damage in Systemic Lupus Erythematosus Is Attributable More to Comorbidity (Hypertension) and Less to Socioeconomic Status
- Abstract Number: 0389
Organ Specific Treatment Patterns of a Real-World, Electronic Health Record Cohort of Patients with Systemic Sclerosis
- Abstract Number: 0931
Oropharyngeal Dysfunction in Patients with Systemic Sclerosis – Results of a Monocentric Clinical Study
- Abstract Number: 1122
Osteoarthritis in a Large Integrated Health System Population: 18-Year Retrospective Review
- Abstract Number: 1121
Osteoarthritis in the Million Veterans Program: Integrating the Electronic Medical Record with Precision Medicine
- Abstract Number: 1110
Osteoarthritis-Related Knee Inflammation Measured by Ultrasound Is Associated with Performance-Based Measures of Function
- Abstract Number: 0122
Osteoporosis Medication Utilization Patterns over Time in the ACR RISE Registry
- Abstract Number: 0321
Outcome Measures in Psoriatic Arthritis Registries Are Very Heterogeneous: A Systematic Literature Review of 27 Registries, or 16183 Patients
- Abstract Number: 1941
Outcome of Giant Cell Arteritis Patients Who Were Primarily Admitted for Venous Thromboembolism Events
- Abstract Number: 1841
Outcomes After Hydroxychloroquine Reduction or Discontinuation in a Multinational Inception Cohort of Systemic Lupus
- Abstract Number: 1226
Outcomes and Efficacy of Selective versus Automatic Switching from Etanercept to a Biosimilar in Inflammatory Arthritis Using Electronic Health Records from UK
- Abstract Number: 0668
Outcomes and Resource Utilization After Total Knee Arthroplasty in Calcium Pyrophosphate Crystal Deposition Disease Patients: Insights from the National Inpatient Sample Database
- Abstract Number: 0983
Outcomes Following Antimalarial Withdrawal in Patients with Quiescent Systemic Lupus Erythematosus
- Abstract Number: 1496
Outcomes of an Evidence Based Guideline for the Treatment of Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome
- Abstract Number: 0430
Outcomes of Coronavirus Disease 2019 Infection Among Patients Living with Rheumatic Diseases: A Matched Cohort Study from a US Multi-Center Research Network
- Abstract Number: L01
Outcomes of COVID-19 Infection in Patients with Rheumatic Diseases in a Multicenter Healthcare System: A Comparative Cohort Study
- Abstract Number: 1424
Outcomes of Hospitalizations for Acute Myocardial Infarction in Patients with ANCA Associated Vasculitis from the National Inpatient Sample
- Abstract Number: 0400
Outcomes of Systemic Sclerosis Hospitalizations by Hospital Teaching Status: Analysis of the National Inpatient Sample
- Abstract Number: 1390
Outcomes of Systemic Sclerosis Patients Who Were Primarily Admitted for Acute Myocardial Infarction from 2016 to 2017: Insights from the National Inpatient Sample
- Abstract Number: 1019
Outdoor Air Pollution and Systemic Lupus Erythematosus
- Abstract Number: 1574
Over Half of Patients with Immune Checkpoint Inhibitor-related Myositis, Myasthenia Gravis and/or Myocarditis Have Autoantibodies: Results from a Systematic Literature Review
- Abstract Number: 0284
Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-induced Lupus Model
- Abstract Number: 0318
Oxylipin Profile Is Associated with Skin Disease and Enthesitis in Psoriatic Disease
- Abstract Number: 0970
Oxylipins Profiles During the Earliest Phases of Rheumatoid Arthritis: Associations with Clinical Stage and Treatment Outcomes
ACR Convergence 2020
November 5-9, 2020. All Virtual.